SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-130042
Filing Date
2023-12-28
Accepted
2023-12-28 16:02:09
Documents
1
Period of Report
2023-12-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333865-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333865-1_4seq1.xml 4 7368
  Complete submission text file 0001104659-23-130042.txt   9134
Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 231522724

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)